A series of novel 5-(benzyloxy)pyridin-2(1H)-ones were designed, synthesized and biologically evaluated for c-Met inhibition. Various amides and benzoimidazoles at C-3 position were investigated. A potent compound 12b with a c-Met IC50 of 12nM was identified. This compound exhibited potent inhibition of EBC-1 cell associated with c-Met constitutive activation and showed high selectivity for c-Met than other tested 11 kinases. The binding model 12b with c-Met was disclosed by docking analysis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2013.02.037 | DOI Listing |
Publication Analysis
Top Keywords
12b c-met
8
c-met
6
novel 5-benzyloxypyridin-21h-one
4
5-benzyloxypyridin-21h-one derivatives
4
derivatives potent
4
potent c-met
4
c-met inhibitors
4
inhibitors series
4
series novel
4
novel 5-benzyloxypyridin-21h-ones
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!